An integration of three approaches to addiction and methadone maintenance treatment: The self-medication hypothesis, the disease model and social criticism

Israel Journal of Psychiatry and Related Sciences

Volumn 39, Issue 2, 2002, Pages 140-151

  Gelkopf, Marc ^a,c,d   Levitt, Shabtai ^d   Bleich, Avi ^a,b,c  

^a LEV HASHARON MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; NARCOTIC AGENT;

ARTICLE; HEROIN DEPENDENCE; HUMAN; PATIENT COMPLIANCE; POLICY; PSYCHOLOGICAL THEORY; SELF MEDICATION; SOCIAL BEHAVIOR;

HEROIN DEPENDENCE; HUMANS; METHADONE; NARCOTICS; PATIENT COMPLIANCE; PSYCHOLOGICAL THEORY; PUBLIC POLICY; SELF MEDICATION; SOCIAL RESPONSIBILITY;

EID: 0036053740     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. NIH-National Institute of Health. Effective medical treatment of opiate addiction. National Institute of Health Consensus Statement 1997;15:1-38.
2. Bell J, Dru A, Fisher B, Levitt S, Sarfraz A. Substitution therapy. Journal of Substance Use and Misuse 2002 (in Press).
3. Bleich A, Adelson M. Opiate addiction as a chronic brain disease: New concept of an old problem, and re-evaluation of methadone treatment. Harefuah 2000;138:154-157 (in Hebrew).
4. Kreek MJ, Reisinger M. The addict as a patient. In: Lowinson JH, Ruiz P, Millman R, Langrod J, editors. Substance abuse: A comprehensive textbook, 3rd Edition, Baltimore, MD: Williams & Wilkins, 1997: pp. 822-854.
5. Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade. Arch Intern Med 1966;118: 304-309.
6. Kreek MJ. Rationale for maintenance pharmacotherapy of opiate dependence, In: O'Brian CP, Jaffe J, editors. Addictive States. Research publications: Association for Research in Nervous and Mental Diseases, 70, New York: Raven, 1992: pp. 210-255.
7. Jaffe JH. Substance related disorders: Introduction and overview. In: Kaplan M, Sadock L, editors. Comprehensive textbook of psychiatry, 1995: pp. 755-775.
8. Alexander BK, Hadaway PF. Opiate addiction: The case for an adaptive orientation. Psychol Bull 1988;92:367-381.
9. Brower KJ, Blow FC, Beresford TP. Treatment implications of chemical dependency models: An integrative approach. J Subst Abuse Treat 1989;6:147-157.
10. Miller N, Gold MS. The disease and adaptive models of addiction: A re-evaluation. J Drug Issues 1990;20:29-35.
11. Lewis DC. A disease model of addiction. In: Miller NS, editor. Principles of addiction medicine. Chevy Chase, MD: American Society of Addiction Medicine, 1994.
12. O'Brian C. A range of research-based pharmacotherapies for addiction. Science 1997;278:66-70.
13. Hagman G. Methadone maintenance counseling. J Subst Abuse Treat 1994;11:405-413.
14. Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L. Psychosocial treatments for cocaine dependence. Arch Gen Psychiatry 1999;56:493-502.
15. rd Edition. Baltimore, MD:Williams & Wilkins, 1997: pp. 90-99.
16. Khantzian EJ. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259-1264.
17. Freud S. The complete letters of Sigmund Freud to Wilhelm Fliess. Masson JM, trans/ed. Cambridge, Mass.: Harvard University, 1987-1985.
18. Leshner AI. Addiction is a brain disease, and it matters. Science 1997;278:45-47.
19. Magura S, Nwakeze P, Demsky S. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998;93:51-60.
20. Wallace J. Modern disease models of alcoholism and other chemical dependencies: The new biopsychosocial models. Drugs Society 1993;8:69-87.
21. Szasz TS. Our rights to drugs: the case for a free market. New York: Praeger, 1992.
22. Goffman I. Stigma: Notes on the management of spoiled identity. Simon & Schuster, 1963.
23. D'Aunno T, Vaughn T. Variations in methadone treatment practice. JAMA 1992;267: 253-258.
24. Farrell M, Ward J, Mattick R, Hall W, Stinson G, des Jarlais D, Gossop M, Strang J. Methadone maintenance treatment in opiate dependence: A review. BMJ 1994;309:997-1001.
25. Strain E, Stitzer M, Liebson I, Bigelow G. Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med 1993;119:23-27.
26. Blaney T, Craig R. Methadone maintenance: Does dose determine differences in outcome? J Subst Abuse Treat 1999;16:221-228.
27. Maremmani I, Zolesi O, Agueci T, Castrogiovanni P. Methadone doses and psychopathological symptoms during methadone maintenance. J Psychoactive Drugs 1993;25:253-256.
28. Curran V, Bolton J, Wanigaratne S, Smith C. Additional methadone increases craving for heroin: A double-blind, placebo controlled study of chronic opiate users receiving methadone substitution treatment. Addiction 1999;94:665-674.
29. Treece C, Nicholson B. DSM-II personality type and dose levels in methadone maintenance patients. J Nerv Ment Dis 1980;168: 621-628.
30. Bleich A, Gelkopf M, Hayward R, Adelson M. A naturalistic study on ending blind dosing in a methadone maintenance clinic. Drug Alcohol Depend 2001;61:191-194.
31. Robles E, Miller F, Gilmore-Thomas K, McMillan D. Implementation of a clinic policy of client-regulated methadone dosing. J Substance Abuse Treatment 2001;3:225-230.
32. Bourgeois P. Disciplining addictions: The bio-politics of methadone and heroin in the United States. Cult Med Psychiatry 2000;24: 165-195.
33. Bleich A, Gelkopf M, Hayward R, Bodner G, Adelson M. Correlates of benzodiazepine abuse in methadone maintenance treatment (MMT) patients: A one year prospective study in an Israeli clinic. Addiction 1999;94: 1533-1540.
34. Gelkopf M, Bleich A, Hayward R, Adelson M. Patient outcomes after initiation of Sabbath closure of a methadone maintenance clinic in Israel. Psychiatr Serv 1998;49: 1483-1485.
35. Jarvick ME. The drug dilemma: Manipulating the demand. Science 1990;53:387-382.
36. Mueser KT, Drake RE, Wallach MA. Dual diagnosis: A review of etiological theories. Addict Behav 1998;23:7217-7234.
37. McLellan AT, Woody GE, O'Brian CP. Development of psychiatric illness in drug abusers: Possible roles of drug preferences. N Engl J Med 1979;301:1310-1314.
38. Bleich A, Gelkopf M. Patterns of psychiatric comorbidity in drug addicts on methadone maintenance in Israel, and its relation to treatment outcome. Jerusalem: The Anti-Drug Authority. 2000 (Hebrew).
39. Gelkopf M, Bleich A, Hayward R, Bodner G, Adelson M. Characteristics of benzodiazepine abuse in methadone maintenance treatment (MMT) patients: A one year prospective study in an Israeli clinic. Alcohol Drug Depend 1999;55:63-68.
40. Preston K, Umbricht A, Epstein DH. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Arch Gen Psychiatry 2000;57:395-404.
41. Drake RE, Brunette MF. Complications of severe mental illness related to alcohol and drug use disorders. In: Galanter M, editor. Recent developments in alcoholism, Vol. 14: The consequences of alcohol. New York: Plenum, 1998: pp. 285-299.
42. Hillman J, Ventura M. We've had a hundred years of psychotherapy and the world's getting worse. San Francisco, CA: Harper, 1993.
43. Woody E, McLellan TM, Luborsky L, O'Brian CP. Psychotherapy in community methadone programs: A validation study. Am J Psychiatry 1995;152:1302-1308.
44. McLellan AT, Arndt IO, Woody GE. Metzger DS. The effects of psychosocial services in substance abuse treatment. JAMA 1993;269:1953-1959.
45. Bollerud K. A model for the treatment of trauma-related syndromes among chemically dependent inpatient women. J Subst Abuse Treat 1990;7:54-67.
46. Weiner H, Shut J. The interaction between counseling and methadone in the treatment of narcotic addicts: The challenge of the counseling relationship. Int J Pharmacol 1975;11:292-298.
47. Belding M, Igushi MY, Lamb RJ. Stages and processes of change as predictors of drug use among methadone maintenance patients. Exp Clin Psychopharmacol 1997;5:65-73.
48. Rosenfeld JM, Tardieu B. From impasse to action. Baltimore, MD: American University. 2000.
49. Walters GD. Drug seeking behavior: Disease or lifestyle. Professional psychology: Research and practice 1992;23:139-145.